Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds
New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
Health News is provided as a service to Byassee Drugs site users by HealthDay. Byassee Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.